Amir Reichman
Förmögenhet: 42 550 $ per 2026-06-30
Förmögenhet: 42 550 $ per 2026-06-30
Amir Reichman was the founder of NeuroDerm Ltd. since 2003, holding the title of Chief Engineer & Senior Scientist from 2003 to 2009.
Mr. Reichman is currently the Chief Executive Officer & Director at Scinai Immunotherapeutics Ltd. since 2021.
Former positions include Head-Global Vaccines Engineering Core Technology at GlaxoSmithKline Pharmaceuticals SA (Belgium) from 2017 to 2021 and Head-Global Vaccines Value Chain Management at Novartis Vaccines & Diagnostics, Inc. (North Carolina) from 2011 to 2015.
Education includes an undergraduate degree from Ben-Gurion University of the Negev and an MBA from The Wharton School of the University of Pennsylvania.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-16 | 67 540 000 ( 0,34 % ) | 42 550 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| BIONDVAX PHARMACEUTICALS LTD | Verkställande Direktör | 2021-03-02 |
| Företag | Position | Slut |
|---|---|---|
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals and vaccines | Företagsledare/Principal | 2021-03-01 |
Novartis Vaccines & Diagnostics, Inc. (North Carolina) | Företagsledare/Principal | 2015-01-01 |
| NEURODERM LTD | Grundare | 2009-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeuroDerm Ltd.
NeuroDerm Ltd. BiotechnologyHealth Technology Develops next-generation drug-device combination solutions for central nervous system disorders | Health Technology |
Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd. Pharmaceuticals: OtherHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes immunomodulation therapies for infectious diseases | Health Technology |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals and vaccines | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Vaccines & Diagnostics, Inc. (North Carolina) |
Välj din utgåva
All finansiell information anpassad till den nationella nivån